An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries

Steven G. Morgan, Chester B. Good, Christine Leopold, Anna Kaltenboeck, Peter B. Bach and Anita Wagner

Health Policy, 2018, vol. 122, issue 9, 1012-1017

Abstract: We sought to estimate size and sources of differences in per capita expenditures on primary care medications in the US versus ten comparable countries combined: Australia, Canada, France, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United Kingdom.

Keywords: Pharmaceuticals; Expenditures; Cost-drivers; Prices; International comparisons; Prescription drugs (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S016885101830246X
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:122:y:2018:i:9:p:1012-1017

DOI: 10.1016/j.healthpol.2018.07.005

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().